Lyell Immunopharma, Inc. (LYEL) Options Statistics & Positioning
Lyell Immunopharma, Inc. (LYEL) options trade at a 30-day at-the-money implied volatility of 496.2%, an IV rank of 100 out of 100 over the past year. The options market prices a ±$12.80 (±68.7%) move in LYEL for the front expiration. Max pain sits at $15 and the put/call open interest ratio is 2.05. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.
Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.
Explore LYEL Options Statistics
Upcoming Earnings
LYEL's next expected earnings date is Aug 9, 2026. Options currently price a ±$12.80 (±68.7%) move for the front expiration.
Explore the payoff profile of option on LYEL for free
Build multi-leg LYEL strategies, visualize payoffs, and scan the full US options universe with OptiView.
LYEL Options FAQ
When is LYEL's next earnings date?
LYEL's next expected earnings date is Aug 9, 2026. Options currently price a ±$12.80 (±68.7%) move for the front expiration.
How often is LYEL options data on this page updated?
All LYEL statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.
Where can I see LYEL max pain, open interest, and implied volatility in detail?
OptiView publishes dedicated LYEL pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.
Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.
Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.